Clinical Utility of Anti-CADM-140/Melanoma Differentiation-Associated Gene 5 Autoantibody Titers in Patients with Juvenile Dermatomyositis and Rapidly Progressive Interstitial Lung Disease

被引：0
|
作者：
Sato, Shinji [1 ]
Kobayashi, Norimoto [2 ]
Yamazaki, Kazuko [3 ]
Suzuki, Yasuo [1 ]
机构：
[1] Tokai Univ, Sch Med, Isehara, Kanagawa 25911, Japan
[2] Shinshu Univ, Sch Med, Matsumoto, Nagano 390, Japan
[3] Yokohama City Univ Med, Yokohama, Kanagawa, Japan
来源：
ARTHRITIS AND RHEUMATISM | 2012年 / 64卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
292
引用
收藏
页码：S128 / S128
页数：1
相关论文
共 50 条
  • [41] Dysregulated CD38 expression on T cells was associated with rapidly progressive interstitial lung disease in anti-melanoma differentiation-associated gene 5 positive dermatomyositis
    Guo, Yixue
    Liu, Hongjiang
    Chen, Bo
    Zhang, Keyi
    Meng, Liye
    Yan, Lin
    Niu, Qian
    Zhang, Junlong
    Yin, Geng
    Li, Yi
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [42] Liver Involvement is Associated with Higher Risk of Rapidly Progressive Interstitial Lung Disease and Mortality in Anti-Melanoma Differentiation-Associated Gene 5 Antibody- Positive Dermatomyositis
    Yang, Xin
    Cui, Xiaoguang
    Yang, Xiao
    Ren, Bincheng
    Cheng, Xiaojing
    Zhao, Xinrui
    Liu, Shanshan
    Tian, Tian
    Zhao, Hui
    Qu, Li
    Li, Xueyi
    JOURNAL OF INFLAMMATION RESEARCH, 2024, 17 : 3101 - 3113
  • [43] Upfront combination therapy in anti-melanoma differentiation-associated gene 5 (MDA5) associated rapidly progressive interstitial lung disease
    Tseng, Chih-Wei
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2024, 27 (06)
  • [44] Clinical Features and Treatment of Dermatomyositis Patients with Anti-CADM-140 (melanoma differentiation-associated protein 5: MDA5) Antibody; Recommendation of Combined Immunosuppressive Therapy with Intensive Intravenous Cyclophosphamide
    Nakashima, Ran
    Hosono, Yuji
    Yukawa, Naoichiro
    Yoshifuji, Hajime
    Kawabata, Daisuke
    Ohmura, Koichiro
    Usui, Takashi
    Fujii, Takao
    Mimori, Tsuneyo
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S83 - S83
  • [45] RAPIDLY PROGRESSIVE INTERSTITIAL LUNG DISEASE WITH ANTI-MELANOMA DIFFERENTIATION-ASSOCIATED PROTIEN-5: A DIAGNOSTIC DILEMMA
    Venkataraman, Varsha
    Dmello, Dayton
    Katyal, Anup
    CHEST, 2020, 158 (04) : 770A - 770A
  • [46] Utility of Anti-Melanoma Differentiation-Associated Gene 5 Antibody Measurement in Identifying Patients With Dermatomyositis and a High Risk for Developing Rapidly Progressive Interstitial Lung Disease: A Review of the Literature and a Meta-Analysis
    Chen, Zhiyong
    Cao, Mengshu
    Nieves Plana, Maria
    Liang, Jun
    Cai, Hourong
    Kuwana, Masataka
    Sun, Lingyun
    ARTHRITIS CARE & RESEARCH, 2013, 65 (08) : 1316 - 1324
  • [47] Interstitial Lung Disease with Anti-melanoma Differentiation-associated Protein 5 Antibody: Rapidly Progressive Perilobular Opacity
    Chino, Haruka
    Sekine, Akimasa
    Baba, Tomohisa
    Kitamura, Hideya
    Iwasawa, Tae
    Okudela, Koji
    Takemura, Tamiko
    Itoh, Harumi
    Sato, Shinji
    Suzuki, Yasuo
    Ogura, Takashi
    INTERNAL MEDICINE, 2019, 58 (18) : 2605 - 2613
  • [48] Identification of Three Different Phenotypes in Anti-Melanoma Differentiation-Associated Gene 5 Antibody-Positive Dermatomyositis Patients: Implications for Prediction of Rapidly Progressive Interstitial Lung Disease
    Xu, Lingxiao
    You, Hanxiao
    Wang, Lei
    Lv, Chengyin
    Yuan, Fenghong
    Li, Ju
    Wu, Min
    Da, Zhanyun
    Wei, Hua
    Yan, Wei
    Zhou, Lei
    Yin, Songlou
    Zhou, Dongmei
    Wu, Jian
    Lu, Yan
    Su, Dinglei
    Liu, Zhichun
    Liu, Lin
    Ma, Longxin
    Xu, Xiaoyan
    Zang, Yinshan
    Liu, Huijie
    Ren, Tianli
    Wang, Fang
    Du, Yan
    Xue, Jing
    Zhang, Miaojia
    Tan, Wenfeng
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 (04) : 609 - 619
  • [49] A fatal interstitial lung disease in an anti-melanoma differentiation-associated gene 5 (anti-MDA5) antibody negative patient with juvenile dermatomyositis
    Yesilbas, Osman
    Yildiz, Mehmet
    Yozgat, Can Yilmaz
    Tahaoglu, Irmak
    Yazan, Hakan
    Cakir, Erkan
    Adrovic, Amra
    Sahin, Sezgin
    Barut, Kenan
    Kasapcopur, Ozgur
    TURKISH JOURNAL OF PEDIATRICS, 2021, 63 (05) : 903 - 908
  • [50] Combination therapy with methylprednisolone, rituximab, and tofacitinib in antimelanoma differentiation-associated 5 gene dermatomyositis with rapidly progressive interstitial lung disease
    Manghani, Mona
    Lim, Weiyen
    Chai, Gin Tsen
    Lim, Xin Rong
    Chua, Choon Guan
    RHEUMATOLOGY & AUTOIMMUNITY, 2024, 4 (02): : 122 - 125
12345